Edesa Biotech (EDSA) Operating Leases (2019 - 2024)
Edesa Biotech (EDSA) posted Operating Leases of $19867.0 for Q3 2024, down 48.82% sequentially from $38817.0 in Q2 2024, and little changed YoY from $19773.0 in Q4 2023.
Edesa Biotech (EDSA) Operating Leases (2019 - 2024) Analysis & Trends
Edesa Biotech has reported Operating Leases for 6 years, with the latest figure at $19867.0 in Q3 2024.
- Quarterly Operating Leases changed 0.48% year-over-year to $19867.0 in Q3 2024, while the trailing twelve-month figure through Sep 2024 was $19867.0 (changed 0.48% YoY) and the FY2024 annual result came in at $19867.0, changed 0.48% from the prior year.
- Operating Leases fell to $19867.0 in Q3 2024 per EDSA's latest filing, from $38817.0 in the prior quarter.
- Over five years, Operating Leases peaked at $176876.0 in Q2 2020 and troughed at $19773.0 in Q3 2023.
- A 5-year average of $91182.9 and a median of $94460.0 in 2020 frame the typical range for Operating Leases.
- The sharpest annual moves came in 2021 and 2023: Operating Leases slumped 76.41% in 2021, then soared 110.97% in 2023.
- Over 5 years, Operating Leases stood at $154800.0 in 2020, then slumped by 35.84% to $99320.0 in 2021, then dropped by 22.85% to $76622.0 in 2022, then grew by 2.21% to $78314.0 in 2023, then slumped by 74.63% to $19867.0 in 2024.
- According to Business Quant data, Operating Leases over the past three periods registered $19867.0, $38817.0, and $78314.0 for Q3 2024, Q2 2024, and Q4 2023 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 137.11 Bn | 129.26 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 84.98 Bn | 76.99 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.52 Bn | 59.33 Bn | 1.37 Bn |
| 4 | Moderna | 53.23 Bn | 48.09 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.23 Bn | 36.14 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 30.65 Bn | 27.34 Bn | 992.69 Mn |
| 7 | Insmed | 27.15 Bn | 25.99 Bn | 358.27 Mn |
| 8 | Royalty Pharma | 26.98 Bn | 26.14 Bn | - |
| 9 | BioNTech SE | 26.78 Bn | 8.39 Bn | 668.28 Mn |
| 10 | Edesa Biotech | 43.15 Mn | 43.15 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2024 | 19,867.00 |
| Jun 30, 2024 | 38,817.00 |
| Dec 31, 2023 | 78,314.00 |
| Sep 30, 2023 | 19,773.00 |
| Jun 30, 2023 | 114,921.00 |
| Mar 31, 2023 | 129,828.00 |
| Dec 31, 2022 | 76,622.00 |
| Mar 31, 2022 | 61,540.00 |
| Sep 30, 2021 | 99,320.00 |
| Jun 30, 2021 | 41,725.00 |
| Mar 31, 2021 | 138,137.00 |
| Dec 31, 2020 | 154,800.00 |
| Sep 30, 2020 | 94,460.00 |
| Jun 30, 2020 | 176,876.00 |
| Mar 31, 2020 | 122,743.00 |
| Dec 31, 2019 | 151,514.00 |